KLK3 and benign prostatic hyperplasia: Treatment of BPH a. Reducing PV and the serum PSA level b. Improving Q-max, QOL, LUTS and nocturia c. Preventing disease progression d.Reduction in the risk of AUR and the need for surgical intervention.